Mynd... Show more
a provider of objective clinical decision support to mental healthcare providers for the treatment of behavioral disorders, including depression, anxiety, bipolar disorder and post-traumatic stress disorder (PTSD)
Industry OtherConsumerSpecialties
A.I.dvisor indicates that over the last year, MYND has been loosely correlated with BAER. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MYND jumps, then BAER could also see price increases.
| Ticker / NAME | Correlation To MYND | 1D Price Change % | ||
|---|---|---|---|---|
| MYND | 100% | +21.52% | ||
| BAER - MYND | 48% Loosely correlated | -2.83% | ||
| AERT - MYND | 36% Loosely correlated | -1.90% | ||
| ABM - MYND | 23% Poorly correlated | +0.75% | ||
| CRAI - MYND | 21% Poorly correlated | +7.08% | ||
| PRDO - MYND | 21% Poorly correlated | +2.84% | ||
More | ||||
| Ticker / NAME | Correlation To MYND | 1D Price Change % |
|---|---|---|
| MYND | 100% | +21.52% |
| Other Consumer Specialties industry (43 stocks) | -3% Poorly correlated | +0.02% |
| Consumer Durables industry (208 stocks) | -3% Poorly correlated | +0.46% |
The RSI Oscillator for MYND moved out of oversold territory on September 17, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 41 similar instances when the indicator left oversold territory. In 35 of the 41 cases the stock moved higher. This puts the odds of a move higher at 85%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Momentum Indicator moved above the 0 level on October 01, 2026. You may want to consider a long position or call options on MYND as a result. In 73 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for MYND just turned positive on October 01, 2026. Looking at past instances where MYND's MACD turned positive, the stock continued to rise in 35 of 42 cases over the following month. The odds of a continued upward trend are 83%.
Following a +6.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where MYND advanced for three days, in 154 of 193 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
MYND may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
MYND moved below its 50-day moving average on September 01, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MYND crossed bearishly below the 50-day moving average on September 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MYND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for MYND entered a downward trend on September 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.238) is normal, around the industry mean (2.806). P/E Ratio (9.123) is within average values for comparable stocks, (48.312). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.327). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.095) is also within normal values, averaging (27.566).
The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. MYND’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MYND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.